Senate Advances Susan Monarez's Nomination as CDC Director Amid Vaccine Controversy
The U.S. Senate health committee voted 12-11 to advance Susan Monarez's nomination as CDC director, highlighting her support for vaccines amid public health challenges.
Joe.My.God.Senate Panel Advances CDC Nominee In 12-11 Vote
ABC NewsSenate committee advances Susan Monarez to be Trump's CDC director
Associated PressSenate committee advances Susan Monarez to be Trump's CDC director
Washington ExaminerSenate panel advances Trump nominee for CDC amid vaccine policy controversy
Roll CallSenate HELP panel advances Monarez for CDC director
Overview
The U.S. Senate health committee voted 12-11 to advance Susan Monarez's nomination as CDC director, reflecting partisan divides over vaccine policies.
Monarez is the first nominee to pass through Senate confirmation under a new 2023 law, marking a significant milestone in the process.
During her confirmation hearing, Monarez emphasized her support for vaccines and public health interventions backed by scientific evidence.
The CDC is currently facing challenges, including staff cuts and a resurgence of measles, which underscores the need for effective leadership.
Monarez, with a doctorate in microbiology and immunology, has extensive experience in health technology and previously served as acting director of the CDC.
Analysis
Sources present a largely neutral, factual account of Susan Monarez's CDC director nomination. They emphasize the procedural vote and include attributed concerns from senators regarding her stance on vaccine policies amidst "turmoil" at the agency, without adopting an editorial tone.